Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation

被引:5
|
作者
Kazmierska, Joanna [1 ,2 ,4 ]
Bajon, Tomasz [1 ]
Winiecki, Tomasz [1 ]
Borowczak, Dominika [1 ]
Bandurska-Luque, Anna [1 ]
Jankowska, Malgorzata [1 ]
Zmijewska-Tomczak, Malgorzata [3 ]
机构
[1] Greater Poland Canc Ctr, Radiotherapy Dept 2, Poznan, Poland
[2] Univ Med Sci, Electroradiol Dept, Poznan, Poland
[3] Greater Poland Canc Ctr, Radiotherapy Dept 1, Poznan, Poland
[4] Greater Poland Canc Ctr, Radiotherapy & Oncol, Garbary 15, PL-61866 Poznan, Poland
关键词
neutrophil-to-lymphocyte ratio; head and neck cancer; prediction; MICROENVIRONMENT; CHEMOTHERAPY; RADIOTHERAPY; MECHANISMS; SURVIVAL; NLR;
D O I
10.5603/RPOR.a2023.0042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The role of host immune system in carcinogenesis and response to treatment is increasingly studied, including predictive potential of circulating neutrophils and lymphocytes. The objective of the study was to evaluate the prognostic val-ue of pre-and post-treatment neutrophil-to-lymphocyte (NLR) for treatment outcome in patients diagnosed with squamous cell carcinoma of head and neck (HNSCC) treated with definitive chemoradiation. Materials and methods: Electronic medical records of patients were evaluated and NLR was calculated. Cox regression was used to assess the impact of selected variables on overall survival (OS), disease specific survival (DSS), progression free sur-vival (PFS) and distant failure free survival (DFFS). Logistic regression was used to estimate odds ratios of complete response with NLR. Results: 317 patients' records were included in the study. Increases in both pre-and post-NLR were associated with decreased OS in univariable analysis [hazard ratio (HR): 2.26 (1.25-4.07), p = 0.0068 and HR: 1.57 (1.03-2.37), p = 0.035 respectively). Post-NLR remained significant for OS in multivariable analysis [HR: 1.93 (1.22-3.1), p = 0.005] as well as for unfavorable DSS [HR: 2.31 (1.22-4.4), p = 0.01]. Pre-treatment NLR and nodal status correlated with shorter DFFS in multivariable analysis [HR 4.1 (1.14-14), p = 0.03 and HR 5.3: (1.62-18), p = 0.0062, respectively]. Strong correlation of increased both pre-and post-NLR with probability of clinical tumor response (CR) was found [odds ratio (OR): 0.23 (0.08-0.6), p = 0.003, and OR: 0.39 (0.2-0.8), p = 0.01 respectively]. Conclusion: NLR evaluated before and post treatment was a strong predictor of unfavorable treatment outcome and can be used for risk evaluation and clinical decision about treatment and post-treatment surveillance.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 50 条
  • [31] Prognostic Significance of Pre-Treatment Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Head and Neck Malignancies
    Sharma, Rupali
    Kalsotra, Gopika
    Mahajan, Deepti
    Kalsotra, Parmod
    Raj, Dev
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, 76 (01) : 567 - 574
  • [32] Prognostic Value of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Head and Neck Malignancies
    Yanish Bhashkar Seetohul
    Vishwambhar Singh
    Rajiv Kumar Jain
    Ashvanee Kumar Chaudhary
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2020, 72 : 128 - 132
  • [33] NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) IS AN INDEPENDENT PREDICTOR OF OUTCOME FOLLOWING COLECTOMY FOR CANCER
    Fancher, T.
    Hsu, M.
    Weiss, A.
    Shia, J.
    Gonen, M.
    Nash, G.
    Temple, L.
    Paty, P.
    Guillem, J.
    Wong, D.
    Weiser, M.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 649 - 649
  • [34] Neutrophil to lymphocyte ratio is a predictor of outcome in metastatic pancreatic cancer patients (MPC) treated with nab-paclitaxel and gemcitabine
    Ventriglia, J.
    Petrillo, A.
    Huerta, M.
    Laterza, M. M.
    Savastano, B.
    Gambardella, V.
    Tirino, G.
    Pompella, L.
    Diana, A.
    Febbraro, A.
    Troiani, T.
    Orditura, M.
    Cervantes, A.
    Ciardiello, F.
    De Vita, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) on overall survival in patients treated with chemoradiotherapy for head and neck cancer
    Makhloufi, S.
    Lefebvre, G.
    Sakji, I.
    Feutry, F.
    Leroy, T.
    Penel, N.
    Coche, B.
    Fourquet, J.
    Ghestem, F.
    Julieron, M.
    Chevalier, D.
    Tresch, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis
    Guan-Jiang Huang
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 5967 - 5968
  • [37] Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis
    Huang, Guan-Jiang
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (12) : 5967 - 5968
  • [38] Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer
    Ku, Ja Yoon
    Roh, Jong-Lyel
    Kim, Sung-Bae
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 417 - 422
  • [39] Impact of Treatment Timing on Disease Outcomes in Patients Treated With Definitive Concurrent Chemoradiation for Head and Neck Cancer
    Steber, C.
    Russell, G.
    Rush, M. C.
    Shenker, R. F.
    Frizzell, B. A.
    Greven, K. M.
    Hughes, R. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E378 - E379
  • [40] Impact of transcutaneous neuromuscular electrical stimulation on dysphagia in patients with head and neck cancer treated with definitive chemoradiation
    Bhatt, Aashish D.
    Goodwin, Nicole
    Cash, Elizabeth
    Bhatt, Geetika
    Silverman, Craig L.
    Spanos, William J.
    Bumpous, Jeffrey M.
    Potts, Kevin
    Redman, Rebecca
    Allison, Wes A.
    Dunlap, Neal E.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (07): : 1051 - 1056